Practical synthesis and SAR study of aliskiren: An orally active human renin inhibitor

被引：0
|
作者：
Dong, Hua [1 ]
Zhang, Zhi-Liu [1 ]
Huang, Lia-Hui [1 ]
Ma, Rujian [1 ]
Chen, Shu-Hui [1 ]
Li, Ge [1 ]
机构：
[1] WuXi PharmaTech Co Ltd, Shanghai 200131, Peoples R China
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2005年 / 230卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
341-MEDI
引用
收藏
页码：U2696 / U2696
页数：1
相关论文
共 50 条
  • [41] Blood pressure lowering with SPP100, a novel orally active renin inhibitor - A pilot study
    Stanton, AV
    Mann, J
    Jensen, C
    O'Brien, ET
    HYPERTENSION, 2001, 38 (03) : 526 - 526
  • [42] ANTIHYPERTENSIVE EFFICACY OF PD-134672 - A NOVEL ORALLY ACTIVE RENIN INHIBITOR
    RYAN, MJ
    BATLEY, BL
    HICKS, GW
    PAINCHAUD, CA
    RAPUNDALO, ST
    TAYLOR, DG
    FASEB JOURNAL, 1991, 5 (06): : A1575 - A1575
  • [43] Practical synthesis of BILA 2157 BS, a potent and orally active renin inhibitor:: Use of an enzyme-catalyzed hydrolysis for the preparation of homochiral succinic acid derivatives
    Beaulieu, PL
    Gillard, J
    Bailey, M
    Beaulieu, H
    Duceppe, JS
    Lavallée, P
    Wernic, D
    JOURNAL OF ORGANIC CHEMISTRY, 1999, 64 (18): : 6622 - 6634
  • [44] RO-42-5892 IS A POTENT ORALLY ACTIVE RENIN INHIBITOR IN PRIMATES
    FISCHLI, W
    CLOZEL, JP
    ELAMRANI, K
    WOSTL, W
    NEIDHART, W
    STADLER, H
    BRANCA, Q
    HYPERTENSION, 1991, 18 (01) : 22 - 31
  • [45] BILA 2157 BS (RI) is a potent, orally active renin inhibitor.
    Panzenbeck, MJ
    Madwed, J
    Harrison, P
    Weldon, SM
    Kerr, S
    Frei, P
    Fogal, SE
    Miner, E
    Desai, S
    Thibeault, D
    Simoneau, B
    Jung, GL
    Lavallee, P
    Anderson, PC
    Winquist, RJ
    FASEB JOURNAL, 1996, 10 (03): : 4030 - 4030
  • [46] Discovery of TAK-272: A Novel, Potent, and Orally Active Renin Inhibitor
    Imaeda, Yasuhiro
    Tokuhara, Hidekazu
    Fukase, Yoshiyuki
    Kanagawa, Ray
    Kajimoto, Yumiko
    Kusumoto, Keiji
    Kondo, Mitsuyo
    Snell, Gyorgy
    Behnke, Craig A.
    Kuroita, Takanobu
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (10): : 933 - 938
  • [47] The Direct Renin Inhibitor Aliskiren Improves Vascular Remodeling in Transgenic Rats Harboring Human Renin and Angiotensinogen Genes
    Savoia, Carmine
    Arrabito, Emanuele
    Parente, Rosa
    Zezza, Luigi
    Sada, Lidia
    Madaro, Luca
    Nicoletti, Carmine
    Muller, Dominik N.
    Volpe, Massimo
    HYPERTENSION, 2011, 58 (05) : E150 - E150
  • [48] The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes
    Savoia, Carmine
    Arrabito, Emanuele
    Parente, Rosa
    Sada, Lidia
    Madaro, Luca
    Nicoletti, Carmine
    Zezza, Luigi
    Alonzo, Alessandro
    Rubattu, Speranza
    Michelini, Serena
    Muller, Dominik N.
    Volpe, Massimo
    CLINICAL SCIENCE, 2013, 125 (3-4) : 183 - 189
  • [49] Development and validation of a radioimmunoassay for the orally active renin inhibitor CI-992 in cynomolgus monkey and human plasma
    Barksdale, CM
    Burger, PJ
    Nordblom, GD
    Cook, JA
    Kirkish, LS
    Michniewicz, BM
    Dudeck, RC
    Hodges, JC
    Klutchko, SR
    Connolly, CJC
    JOURNAL OF CLINICAL LIGAND ASSAY, 1997, 20 (03): : 251 - 257
  • [50] DESIGN AND SYNTHESIS OF AN ORALLY POTENT HUMAN RENIN INHIBITOR CONTAINING A NOVEL AMINO-ACID, CYCLOHEXYLNORSTATINE
    IIZUKA, K
    KAMIJO, T
    HARADA, H
    AKAHANE, K
    KUBOTA, T
    UMEYAMA, H
    KISO, Y
    JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1989, (21) : 1678 - 1680
12345